Literature DB >> 21675423

Cancer survival in Singapore, 1993-1997.

K S Chia1.   

Abstract

The Singapore cancer registry is a national registry established in 1968. Cancer registration is done by passive methods. The registry contributed survival data on 45 cancer sites or types registered during 1993-1997. Data on 34 cancers registered during 1968-1997 were utilized for survival trend by period and cohort approaches. Follow-up was done by passive methods, with median follow-up ranging between 2-72 months for different cancers. The proportion with histologically verified diagnosis for various cancers ranged between 27-100%; death certificates only (DCOs) comprised 0-7%; 76-100% of total registered cases were included for the survival analysis. The top-ranking cancers on 5-year age-standardized relative survival rates were nonmelanoma skin (96%), thyroid (90%), testis (88%), corpus uteri (77%), breast (74%), Hodgkin lymphoma (73%) and penis (70%). Five-year relative survival by age group showed either a decreasing trend with increasing age groups or was fluctuating. Localized stage of disease ranged between 18-65% for various cancers and survival decreased with increasing extent of disease. Period survival closely predicted survival experience of cancers diagnosed in that period, and an increasing trend in period survival over different periods indicated an improved prognosis for cancers diagnosed in those calendar periods.

Entities:  

Mesh:

Year:  2011        PMID: 21675423

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  3 in total

1.  A cross sectional study on the motivators for Asian women to attend opportunistic mammography screening in a private hospital in Malaysia: the MyMammo study.

Authors:  Norhashimah Hassan; Weang Kee Ho; Shivaani Mariapun; Soo Hwang Teo
Journal:  BMC Public Health       Date:  2015-06-12       Impact factor: 3.295

2.  Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.

Authors:  Soheil Hassanipour; Hamed Delam; Morteza Arab-Zozani; Elham Abdzadeh; Seyyed Ali Hosseini; Hossein-Ali Nikbakht; Mahdi Malakoutikhah; Mohammad Taghi Ashoobi; Mohammad Fathalipour; Hamid Salehiniya; Shirin Riahi
Journal:  Ann Glob Health       Date:  2020-01-02       Impact factor: 2.462

Review 3.  The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.

Authors:  Soheil Hassanipour; Mouhebat Vali; Saber Gaffari-Fam; Hossein-Ali Nikbakht; Elham Abdzadeh; Farahnaz Joukar; Akram Pourshams; Afshin Shafaghi; Mahdi Malakoutikhah; Morteza Arab-Zozani; Hamid Salehiniya; Fariborz Mansour-Ghanaei
Journal:  EXCLI J       Date:  2020-01-13       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.